LINACS

Drug Index Methods Publications News About

Explore Monoclonal Antibodies (mAbs) Targeted Therapy Antibody-Drug Conjugates (ADCs) Immunotherapy Gene Therapy

Home › Targeted Therapy › PARP inhibitors

Drug Class

PARP inhibitors

Niraparib

Olaparib Rucaparib

Talazoparib

LINACS · Living systematic review on the safety of SBRT combined with systemic therapies
EORTC-ESTRO · OligoCare · PROSPERO CRD42024559453